Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience

Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience

Bibliographic Details
Main Authors:	Ocvirk, Janja, Moltara, Maja Ebert, Mesti, Tanja, Boc, Marko, Rebersek, Martina, Volk, Neva, Benedik, Jernej, Hlebanja, Zvezdana
Format:	Online
Language:	English
Published:	De Gruyter 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852968/

Similar Items

Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience
by: Ocvirk Janja, et al.
Published: (2016-06-01)

Efficacy of first-line systemic treatment in correlation with BRAF V600E and different KRAS mutations in metastatic colorectal cancer – a single institution retrospective analysis
by: Rebersek, Martina, et al.
Published: (2011)

Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
by: Mesti, Tanja, et al.
Published: (2015)

Malignant gliomas: old and new systemic treatment approaches
by: Mesti Tanja, et al.
Published: (2016-06-01)

Malignant gliomas: old and new systemic treatment approaches
by: Mesti, Tanja, et al.
Published: (2016)

Observational cohort study focused on treatment continuity of patients administered XELOX plus bevacizumab for previously untreated metastatic colorectal cancer
by: Kotaka, Masahito, et al.
Published: (2016)

Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis
by: Botrel, Tobias Engel Ayer, et al.
Published: (2016)

The cost of systemic therapy for metastatic colorectal carcinoma in Slovenia: discrepancy analysis between cost and reimbursement
by: Mesti Tanja, et al.
Published: (2015-06-01)

The cost of systemic therapy for metastatic colorectal carcinoma in Slovenia: discrepancy analysis between cost and reimbursement
by: Mesti, Tanja, et al.
Published: (2015)

Previously treated versus untreated scoliosis: are results different?
by: Zaina, Fabio, et al.
Published: (2014)

Management of cetuximab-induced skin toxicity with the prophylactic use of topical vitamin K1 cream
by: Ocvirk, Janja
Published: (2010)

Introducing candesartan 32 mg plus hydrochlorothiazide 25 mg in previously untreated patients with severe essential hypertension
by: Baumgart, Peter, et al.
Published: (2011)

Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer
by: Kim, Seung Tae, et al.
Published: (2016)

Phase II study of the immune-checkpoint inhibitor ipilimumab plus dacarbazine in Japanese patients with previously untreated, unresectable or metastatic melanoma
by: Yamazaki, N., et al.
Published: (2015)

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
by: Velenik, Vaneja, et al.
Published: (2011)

Metabolic Impact of Anti-Angiogenic Agents on U87 Glioma Cells
by: Mesti, Tanja, et al.
Published: (2014)

Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non–Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials
by: Langer, Corey J., et al.
Published: (2016)

Tallimustine in advanced previously untreated colorectal cancer, a phase II study.
by: Punt, C. J., et al.
Published: (1996)

Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas
by: Nemoto, Kenji, et al.
Published: (2002)

Role of inflammation in previously untreated macular edema with branch retinal vein occlusion
by: Noma, Hidetaka, et al.
Published: (2014)

CHARACTERISTICS OF RENIN PROFILE AND PARAMETERS OF ARTERIAL STIFFNESS IN PATIENTS WITH PREVIOUSLY UNTREATED HYPERTENSION
by: O. A. Kravtsova, et al.
Published: (2014-01-01)

Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia
by: Hill, Brian T, et al.
Published: (2015)

Triplet Chemotherapy (FOLFOXIRI) Plus Bevacizumab Versus Doublet Chemotherapy (FOLFOX/FOLFIRI) Plus Bevacizumab in Conversion Therapy for Metastatic Colorectal Cancer: a Meta-Analysis
by: Lin Shui, et al.
Published: (2018-08-01)

Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer
by: Geva, Ravit, et al.
Published: (2013)

Activity and Safety of Bevacizumab Plus Fotemustine for Recurrent Malignant Gliomas
by: Vaccaro, V., et al.
Published: (2014)

Liver resection following FOLFOXIRI plus bevacizumab: a detailed pathological review
by: Walter, H, et al.
Published: (2013)

Efficacy of XELOX plus Bevacizumab in Brain Metastasis from Rectal Cancer
by: Yoshida, Yoichiro, et al.
Published: (2014)

A Case of Biphasic Pulmonary Blastoma Treated with Carboplatin and Paclitaxel plus Bevacizumab
by: Sakata, Shinya, et al.
Published: (2015)

Bevacizumab plus cisplatin and helical tomotherapy in treatment of locally advanced nasopharyngeal carcinoma
by: Li, Jianxiong, et al.
Published: (2015)

Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma
by: Fu, Zhiying, et al.
Published: (2014)

Sudden visual loss in the untreated eye of a patient with neovascular glaucoma following an intravitreal bevacizumab injection: A case report
by: XU, DING, et al.
Published: (2013)

A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis†
by: Furuse, Motomasa, et al.
Published: (2016)

The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer
by: Oblak, Irena, et al.
Published: (2013)

A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a meta-analysis
by: Ocvirk, Janja, et al.
Published: (2013)

Cetuximab in preoperative treatment of rectal cancer – term outcome of the XERT trial
by: Velenik, Vaneja, et al.
Published: (2012)

Ocular changes in metastatic melanoma patients treated with MEK inhibitor cobimetinib and BRAF inhibitor vemurafenib
by: Gavric Ana Ursula, et al.
Published: (2018-01-01)

A Two-Gene Signature, SKI and SLAMF1, Predicts Time-to-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia
by: Schweighofer, Carmen D., et al.
Published: (2011)

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)
by: Al-Kali, Aref, et al.
Published: (2010)

Identification of a subpopulation of MeCCNU resistant cells in previously untreated Lewis lung tumours.
by: Stephens, T. C., et al.
Published: (1984)

A cross-sectional study of personality traits in women previously treated or untreated for alcohol use disorders
by: Östlund, Anette, et al.
Published: (2007)